Australia, Oct. 16 -- NIRO Brands Pty. Ltd., owns the trademark (2633494) for 'Curbi' till March 7, 2036.

Status: registered: Registered/protected

Class: 5 [pharmaceuticals; pills being pharmaceuticals; pharmaceutical drugs; pharmaceutical substances; tablets being pharmaceuticals; pharmaceutical products and preparations; pharmaceuticals containing active chemical ingredients; homeopathic pharmaceuticals; pharmaceutical and medical preparations; pharmaceutical substances and preparations; pharmaceuticals containing active chemical agents; pharmaceuticals, medical and veterinary preparations; pills [pharmaceuticals]; pharmaceutical preparations and substances; pastilles being pharmaceuticals; antibacterial pharmaceuticals; pharmaceutical products for use by humans; chemical products for pharmaceutical use; pharmaceuticals for the treatment of infectious diseases; chemical products for pharmaceutical purposes; pharmaceutical preparations; anti-diabetic pharmaceuticals; pharmaceutical preparations and substances with analgesic properties; lozenges being pharmaceuticals; pharmaceutical products, medical and veterinary preparations; ethanol for pharmaceutical purposes; pharmaceuticals for the prevention and treatment of cancer; pharmaceutical pills; cardiovascular pharmaceuticals; pharmaceuticals for the treatment of bone diseases; tablets [pharmaceuticals]; pharmaceutical tablets; pharmaceuticals for the treatment of cancer; pharmaceutical preparations for human purposes; pharmaceutical antiallergic preparations and substances; pharmaceuticals for the treatment of viral diseases; pastilles [pharmaceuticals]; dietary supplements for pharmaceutical use; pharmaceutical preparations for human use; chemical preparations for pharmaceutical use; antidiabetic pharmaceuticals; pharmaceuticals containing lactic acid bacteria; elixirs [pharmaceutical preparations]; dietary supplements for pharmaceutical purposes; chemical preparations for pharmaceutical purposes; propolis for pharmaceutical purposes; pharmaceutical preparations for health care; pharmaceuticals for ophthalmological use; pharmaceutical preparations for the treatment of various diseases; pharmaceutical preparations containing hormones for human beings; medicine; alcohol for pharmaceutical purposes; medicines; lozenges [pharmaceuticals]; pharmaceutical preparations and substances with antipyretic properties; clay for pharmaceutical use; pharmaceutical preparations and substances with anti-inflammatory properties; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical anti-allergic preparations and substances; pharmaceutical preparations containing hormones for humans; acids for pharmaceutical purposes; chemical products for therapeutic use; topical pharmaceutical preparations; drugs for medical use; drugs for medical purposes; clay for pharmaceutical purposes; peptones for pharmaceutical purposes; pills for pharmaceutical purposes; chemical products for therapeutical use; pharmaceutical preparations containing active chemical ingredients; pharmaceutical pastilles; gelatin capsules for pharmaceuticals; pharmaceutical cough preparations; stimulants for pharmaceutical purposes; iodine for pharmaceutical purposes; pharmaceutical preparations for diagnostic purposes; pharmaceutical preparations being hormone preparations for human use; antibacterial pharmaceutical preparations; aldehydes for pharmaceutical purposes; pharmaceutical preparations containing active chemical agents; drug delivery agents that facilitate the delivery of pharmaceutical preparations; pharmaceutical cold preparations; chemical products for therapeutical purposes; charcoal for pharmaceutical purposes; pharmaceutical products for the prevention of diseases of the endocrine system; iodides for pharmaceutical purposes; human plasma protein being pharmaceutical preparations; chemicals for medical use; therapeutic drugs and agents; pharmaceutical products for the treatment of disorders of the endocrine system; ethers for pharmaceutical purposes; diagnostic agents for pharmaceutical use; chemical products for medical use; pharmaceutical preparations and substances for use in oncology; pharmaceutical products for the treatment of diseases caused by bacteria; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations and substances for the treatment of cancer; medicinal substances and preparations; starch and starch products for pharmaceutical purposes; pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders; menthol for pharmaceutical purposes; dermatological pharmaceutical substances; chemical products for therapeutic purposes; human coagulation factors being pharmaceutical preparations; ocular pharmaceuticals; pharmaceutical agents affecting metabolism; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical and biological preparations for diagnostic purposes; pharmaceutical preparations and substances for the treatment of diabetes; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations and biological preparations for diagnostic purposes; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical products for use in hematology; potassium preparations for pharmaceutical purposes; pharmaceutical products for the prevention of disorders of the endocrine system; pharmaceutical products for the prevention of diabetes; chemicals for medical purposes; chemico-pharmaceutical products; pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders; pharmaceutical preparations for skincare; pharmaceutical skin lotions; pharmaceutical preparations for skin care; antiepileptic pharmaceutical preparations; medicinal preparations and substances; pharmaceutical products for the prevention of diseases of the nervous system; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for treating cardiovascular diseases; human coagulation factors [pharmaceutical preparations]; pharmaceutical preparations for use in immunotherapies; pharmaceutical lozenges; medicinal healthcare preparations; pharmaceutical preparations and substances for the prevention of cardiovascular diseases and disorders; pharmaceutical solutions used in dialysis; pharmaceutical preparations for the treatment of rare diseases; pharmaceutical preparations for topical use; capsules, empty, for pharmaceuticals; flour for pharmaceutical purposes; pharmaceutical preparations containing amino acids; biochemical drugs; mineral salts for pharmaceutical use; pharmaceutical and veterinary preparations for medical purposes; phosphates for pharmaceutical purposes; pharmaceutical preparations for the prevention and treatment of hypertension; dermatological pharmaceutical products; synthetic peptides for pharmaceutical purposes; diagnostic agents for pharmaceutical purposes; pharmaceutical compositions containing stem cells; pharmaceutical products for the prevention of diseases of the musculoskeletal system; pharmaceutical preparations and substances for the prevention of diabetes; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the treatment of hypertension; aluminium acetate for pharmaceutical purposes; lactose for pharmaceutical purposes; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical products for the prevention of diseases caused by bacteria; chemical products for medical purposes; pharmaceutical preparations for the treatment of chemical imbalances; pharmaceutical preparations and substances for the prevention of metabolic diseases and disorders; liquorice for pharmaceutical purposes; medicines for human purposes; pharmaceutical products for the prevention of disorders of the cardiovascular system; aluminum acetate for pharmaceutical purposes; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; human plasma protein [pharmaceutical preparations]; pharmaceutical preparations for the treatment of diabetes; mineral salts for pharmaceutical purposes; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceuticals for treating the symptoms of radiation sickness; magnesium salts for pharmaceutical use; empty capsules for pharmaceuticals; parapharmaceutical preparations; pharmaceutical preparations for the prevention and treatment of skin diseases; pharmaceutical preparations for activating cellular function; pharmaceutical preparations for the prevention and treatment of cancer; psychedelic compounds for pharmaceutical use; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations and substances for use in the field of anesthesia; gelatine capsules for pharmaceuticals; biochemical drug; yeast for pharmaceutical use; pharmaceutical preparations for the treatment of Parkinson's disease; psychotropic drugs for pharmaceutical use; pharmaceutical preparations for treating hypertension; crude drugs; pharmaceutical preparations for dental purposes; guaiacol for pharmaceutical purposes; pharmaceutical products for the prevention of disorders of the musculoskeletal system; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the treatment of cardiovascular disease; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for treating chemical imbalances; yeast for pharmaceutical purposes; psychedelic compounds for pharmaceutical purposes; capsules sold empty for pharmaceuticals; medicated foodstuff additives for pharmaceutical use; pharmaceutical preparations for the prevention and treatment of skin disorders; esters for pharmaceutical purposes; pharmaceutical products for use in organ transplantation; pharmaceuticals for the treatment of erectile dysfunction; pharmaceutical preparations for cancer imaging, diagnosis and monitoring; psychotropic drugs for pharmaceutical purposes; food esters for pharmaceutical use; pharmaceutical products for the treatment of disorders caused by bacteria; chemical preparations for therapeutical use; psychotropic compounds for pharmaceutical use; pharmaceutical preparations for dental use; magnesium salts for pharmaceutical purposes; pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations for the treatment of the skin; pharmaceuticals for treating respiratory diseases; pharmaceutical preparations for the prevention of diabetes; pharmaceutical preparations for the preservation and storage of human organs; syrups for pharmaceutical purposes; phenol for pharmaceutical purposes; pharmaceutical preparations for the treatment of cancer; human albumin [pharmaceutical preparations]; diagnostic preparations for medical and pharmaceutical use; adhesive patches incorporating pharmaceutical products; biotechnological preparations for medical use; pharmaceutical preparations and substances for use in the field of anaesthesia; intravenous fluids used for the delivery of pharmaceutical preparations; decoctions for pharmaceutical purposes; pharmaceutical preparations containing stem cells; chemical preparations for therapeutic use; caustics for pharmaceutical purposes; pharmaceutical preparations for the prevention of diseases of the endocrine system; oils for pharmaceutical purposes; pharmaceutical preparations for the prevention and treatment of cancer and tumors; adhesive patches containing pharmaceutical products; crude medicines; psychedelic drugs for pharmaceutical use; pharmaceutical preparations for the prevention of tumors; catechu for pharmaceutical purposes; ethyl alcohol for pharmaceutical purposes; pharmaceutical products for the prevention of disorders of the metabolic system; psychotropic compounds for pharmaceutical purposes; medicinal preparations; pharmaceutical products for the treatment of diseases of the genitourinary system; thymol for pharmaceutical purposes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic system; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the musculoskeletal system; radiopharmaceutical preparations; pharmaceutical antitussive-cold preparations; psychedelic drugs for pharmaceutical purposes; pharmaceutical preparations for the peripheral nervous system; bismuth preparations for pharmaceutical purposes; malt for pharmaceutical purposes; pharmaceutical products for the prevention of diseases of the genitourinary system; cachets for pharmaceutical purposes; pharmaceutical preparations for the treatment of disorders of the endocrine system; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of hypercholesterolemia; chemical preparations for therapeutical purposes; biochemical medicines; psychedelics for pharmaceutical use; chemical preparations for medical use; medicated foodstuff additives for pharmaceutical purposes; pharmaceutical products for the prevention of autoimmune diseases; capsules made of dendrimer-based polymers, for pharmaceuticals; pharmaceutical preparations for treating metabolic disorders; pharmaceutical preparations containing caffeine; pharmaceutical products for the treatment of disorders of the genitourinary system; pharmaceutical preparations and substances for use in gynecology; pharmaceutical preparations for peripheral nervous system; pharmaceutical preparations for the prevention of disorders of the endocrine system; magnesia for pharmaceutical purposes; medicinal health care preparations; milk sugar for pharmaceutical purposes; plant extracts for pharmaceutical use; pharmaceutical preparations for imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of viral diseases]

Type of Mark: Word

Date of Acceptance: May 12

Registration Advertised: Oct. 15

For further details contact NIRO Brands.

The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2633494.

Disclaimer: Curated by HT Syndication.